• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Innovus Pharmaceuticals Inc

+ Add to Watchlist

INNV:US

0.2390 USD 0.0010 0.42%

As of 17:20:00 ET on 07/09/2014.

Snapshot for Innovus Pharmaceuticals Inc (INNV)

Open: 0.2390 Day's Range: 0.2390 - 0.2400 Volume: 13,000
Previous Close: 0.2400 52wk Range: 0.1105 - 1.1600 1-Yr Rtn: -31.71%

Stock Chart for INNV

No chart data available.
  • INNV:US 0.2390
  • 1D
  • 1M
  • 1Y
0.2400
Interactive INNV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INNV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.2600
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 5.69
Shares Outstanding (M) 23.82
30 Day Average Volume 16,624
Price/Book (mrq) 12.7525
Price/Sale (ttm) 30.6671
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INNV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INNV

Innovus Pharmaceuticals, Inc. researches and develops medical drugs. The Company developed and has the right to receive half of the net revenues for the licensing and commercialization of a liver cancer drug, markets an over-the-counter arthritis pain relief cream, and markets an over-the-counter mouth wash.

Bassam B DamajPresident/CEOLynnette DillenExec VP/CFO
Randy BerholtzSecy/Acting General Counsel
More Company Profile & Key Executives for INNV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil